| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7dfd84f9157ae12c41e319ec325338d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04 |
| filingDate |
2008-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79c2a753ca1533726a0daa5171d1f768
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_031f2d426eb052281729afb13f89a7b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e6bc13d665afa4cade279df63556c5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ecb61d0d1784ca08905295874b18fe3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dabb1f8dbbb461f80d159518d6d9c340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f84e104f869f0142fb1449eb5c20fa9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6f5e08a4cc515a4411fcbcc765b6978
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20f8607f410c2c8057c68aaa3d5b37b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c6d0887f454f4a5bafece4bc6361b8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_152e4b5d930b86e6b4105051ea88669b |
| publicationDate |
2011-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7867980-B2 |
| titleOfInvention |
Lincosamide derivatives and antimicrobial agents comprising the same as active ingredient |
| abstract |
An objective of the present invention is to provide compounds of formula (I) or their pharmacologically acceptable salts or solvates wherein A represents aryl while R 1 represents a five- or six-membered monocyclic heterocyclic group, or A represents a four- to six-membered monocyclic heterocyclic group while R 1 represents aryl or a five- or six-membered monocyclic heterocyclic group; R 2 represents a hydrogen atom or C 1-6 alkyl; R 3 represents C 1-6 alkyl or C 3-6 cycloalkyl-C 1-4 alkyl; R 4 , R 5 , and R 6 represent a hydrogen atom; R 7 represents C 1-6 alkyl; and m is 1 to 3. The compounds are novel lincosamide derivatives that have a potent activity against resistant Streptococcus pneumoniae . Further, the compounds are usable as antimicrobial agents and are useful for preventing or treating bacterial infectious diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11566039-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11767341-B2 |
| priorityDate |
2007-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |